Your browser doesn't support javascript.
loading
Risk Minimization of Antibody-Drug Conjugates in Oncology: A Review.
Lievano, Fabio A; Scarazzini, Linda J; Tyczynski, Jerzy E; Schubert, Charles M; Renz, Cheryl L.
Afiliação
  • Lievano FA; Pharmacovigilance and Patient Safety, AbbVie, Inc., 1 North Waukegan Road, AP51, North Chicago, IL, 60064, USA. Fabio.lievano@abbvie.com.
  • Scarazzini LJ; Pharmacovigilance and Patient Safety, AbbVie, Inc., 1 North Waukegan Road, AP51, North Chicago, IL, 60064, USA.
  • Tyczynski JE; Pharmacovigilance and Patient Safety, AbbVie, Inc., 1 North Waukegan Road, AP51, North Chicago, IL, 60064, USA.
  • Schubert CM; Pharmacovigilance and Patient Safety, AbbVie, Inc., 1 North Waukegan Road, AP51, North Chicago, IL, 60064, USA.
  • Renz CL; Pharmacovigilance and Patient Safety, AbbVie, Inc., 1 North Waukegan Road, AP51, North Chicago, IL, 60064, USA.
Drug Saf ; 44(7): 733-742, 2021 07.
Article em En | MEDLINE | ID: mdl-33988833
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article